CAPTRUST Financial Advisors’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,909
| Closed | -$700K | – | 2521 |
|
|
2025
Q1 | $700K | Sell |
7,909
-422
| -5% | -$37.4K | ﹤0.01% | 1460 |
|
|
2024
Q4 | $727K | Sell |
8,331
-9,573
| -53% | -$835K | ﹤0.01% | 1407 |
|
|
2024
Q3 | $1.66M | Buy |
17,904
+582
| +3% | +$53.8K | ﹤0.01% | 933 |
|
|
2024
Q2 | $1.87M | Sell |
17,322
-7,801
| -31% | -$841K | 0.01% | 855 |
|
|
2024
Q1 | $2.38M | Sell |
25,123
-13,625
| -35% | -$1.29M | 0.01% | 735 |
|
|
2023
Q4 | $3.57M | Sell |
38,748
-12,720
| -25% | -$1.17M | 0.01% | 676 |
|
|
2023
Q3 | $2.58M | Buy |
51,468
+1,663
| +3% | +$83.5K | 0.01% | 758 |
|
|
2023
Q2 | $3.15M | Buy |
49,805
+22,227
| +81% | +$1.4M | 0.01% | 660 |
|
|
2023
Q1 | $1.24M | Buy |
27,578
+8,316
| +43% | +$374K | 0.01% | 928 |
|
|
2022
Q4 | $844K | Buy |
19,262
+2,219
| +13% | +$97.2K | ﹤0.01% | 1063 |
|
|
2022
Q3 | $1.12M | Sell |
17,043
-31
| -0.2% | -$2.04K | 0.01% | 863 |
|
|
2022
Q2 | $862K | Buy |
17,074
+868
| +5% | +$43.8K | 0.01% | 907 |
|
|
2022
Q1 | $1.04M | Buy |
16,206
+401
| +3% | +$25.6K | 0.01% | 842 |
|
|
2021
Q4 | $1.69M | Buy |
15,805
+964
| +6% | +$103K | 0.01% | 613 |
|
|
2021
Q3 | $1.53M | Buy |
14,841
+2,503
| +20% | +$257K | 0.01% | 599 |
|
|
2021
Q2 | $1.09M | Hold |
12,338
| – | – | 0.01% | 689 |
|
|
2021
Q1 | $1.2M | Buy |
12,338
+131
| +1% | +$12.7K | 0.01% | 629 |
|
|
2020
Q4 | $1.37M | Sell |
12,207
-674
| -5% | -$75.6K | 0.02% | 499 |
|
|
2020
Q3 | $1.21M | Hold |
12,881
| – | – | 0.02% | 450 |
|
|
2020
Q2 | $1.02M | Buy |
12,881
+1,600
| +14% | +$126K | 0.02% | 497 |
|
|
2020
Q1 | $644K | Buy |
11,281
+80
| +0.7% | +$4.57K | 0.01% | 522 |
|
|
2019
Q4 | $921K | Buy |
+11,201
| New | +$921K | 0.01% | 519 |
|